Beilstein J. Nanotechnol.2012,3, 444–455, doi:10.3762/bjnano.3.51
and by activating the immune system.
Keywords: cell-baseddelivery; chemotherapeutic prodrug; magnetic Fe/Fe3O4 nanoparticles; SN38; Introduction
Irinotecan (CPT-11) is a potent chemotherapeutic prodrug against various types of cancer, such as colorectal, lung, and ovarian cancer [1][2][3][4][5]. It
physiological conditions, which is highly desired for a cell-baseddelivery system. We have established that when Mo/Ma cells are used as carriers, the tumor-homing process takes about one day. Their robust stability will ensure the integrity of the MNPs after delivery to the tumor site.
The uptake efficiency
PDF
Scheme 1:
Preparation of core/shell Fe/Fe3O4 magnetic nanoparticles (MNPs).